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The concept that a direct interaction between Ca*+ and phospholipids is a major factor in membrane 
fusion reactions is questioned. Attention is drawn to a number of findings on associations between fusion 
and the proteolysis of membrane proteins. It is proposed that hydrophobic polypeptides, which are 
functionally comparable to the fusogenic proteins of certain viruses but which are produced in cells by the 
endogenous proteolysis of membrane and cellular proteins, may induce membrane fusion reactions in vivo. 
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1. rNTR~DUCTION 
Membrane fusion is a biological phenomenon of 
major importance because it is an essential feature 
of innumerable cellular functions, including cell 
fusion which is a special case that occurs in a com- 
paratively limited number of situations. Of these, 
fertilization, the fusion of myoblasts in the 
development of skeletal muscle, and cell fusion in- 
duced by Sendai virus have probably been studied 
the most extensively. Also, cell fusion induced by 
poly(ethylene glycol) has recently achieved a 
special importance as a laboratory tool for the pro- 
duction of monoclonal antibodies, despite the fact 
that the mechanism of cell fusion involved is not 
fully understood. 
This article reviews some recent studies on fu- 
sion reactions in cells and in model systems. It also 
develops a new proposal for the mechanism of 
cellular membrane fusion reactions. 
2. MEMBRANE PROTEINS 
2.1. Aggregation of integral proteins 
It has been established from model experiments 
that membranes can be fused by electrical [I] or 
chemical f2] stimuli but, apart from virus-induced 
membrane fusion, unequivocal evidence is lacking 
on the molecular nature of the physiologic~/ 
pathological stimuli that initiate membrane fusion 
in living cells. Although the central event of mem- 
brane fusion is the interaction and fusion of the 
phospholipid components of two closely apposed 
membranes, the minimum area of contact between 
the two bilayers that is necessary for fusion to 
develop is also unknown. It is quite probably very 
small, perhaps about 500 A in radius 131, but a suf- 
ficient area of free lipid bilayer may not be avail- 
able in membranes in vivo unless a change in 
molecular organisation is induced as an early event 
in the fusion process. 
In [4] it was proposed that the movement of in- 
tramembranous particles and the lateral mobility 
of integral proteins is of importance in biomem- 
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brane fusion reactions because of the movement of 
intramembranous particles seen in preparations of 
erythrocyte membranes treated with Sendai virus 
[5]. It was thought that fusion might then proceed 
by interdigitation in the two membranes of ag- 
gregated membrane proteins, and the areas of free 
lipid bilayer arising from protein aggregation were 
not considered to be of any significance. Shortly 
afterwards it was suggested that fusion may occur 
in the areas of membrane that are free from in- 
tegral proteins [6]. This is consistent with the abili- 
ty of lipid vesicles to fuse readily under ap- 
propriate conditions, and also with many [7-111 
but not all [12] observations on the fusion of 
biomembranes. It is noteworthy, however, that 
clearing of intramembranous particles from the 
sites of membrane fusion was not found when 
rapid freezing techniques were applied to exocyto- 
sis in rat mast cells [13]. Protein clearing, or at 
least clearing of the extent that has been observed, 
may therefore be an artefact and this point remains 
to be resolved by further experimental work. 
Some interesting comparative findings have 
recently been reported on intramembranous par- 
ticles in mouse L cells and fusion-deficient sub- 
lines treated with poly(ethylene glycol) (PEG) [ 141. 
With 50% PEG, 90% of the parental L cells were 
fused and cold-induced particle aggregation was 
extensive. By contrast, identical treatment of 
fusion-deficient cell lines showed neither extensive 
fusion nor particle aggregation, but higher concen- 
trations of PEG caused extensive fusion and parti- 
cle aggregation was then seen. Fusion and aggrega- 
tion were, however, not invariably related since no 
measurable aggregation was seen with low levels of 
fusion in fusion-deficient cells. 
2.2. Proteolysis 
Ca2+ is important both in cell fusion in par- 
ticular and in membrane fusion in general. For ex- 
ample, fertilization requires Ca2+ as does the fu- 
sion of myoblasts, and many exocytosis reactions 
are Ca2+ -dependent [4]. 
Is Ca2+ involved in the putative lateral displace- 
ments of membrane proteins at the sites of fusion? 
The influx of Ca2+ into cells that is observed in 
secretion might induce a contraction of filamen- 
tous proteins, attached to intramembranous par- 
ticles, which drags the integral proteins away and 
creates bald patches in the plasma membrane. 
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Should a similar process occur in the membrane of 
a secretory vesicle, membrane fusion in exocytosis 
could result when a random collision brings pro- 
tein-free patches on the two membranes into ap- 
position [3]. The integral proteins of the human 
erythrocyte membrane are normally unable to 
move because some of them are attached, via 
ankyrin, to the underlying membrane skeleton of 
spectrin and actin; a similar situation may apply in 
other cells that contain structures which are com- 
parable to the spectrin-actin proteins of the 
erythrocyte [ 15,161. In these cases, lateral move- 
ment of the integral proteins and randomly 
generated protein-free patches for fusion would 
probably result from the endogenous proteolysis 
of key proteins in the network such as ankyrin 
(band 2.1). Proteolysis could also release integral 
membrane proteins that are attached to contractile 
networks. 
In this connection, we have observed that 
human erythrocytes will fuse on treatment with ex- 
ogenous proteolytic enzymes, e.g., subtilisin, and 
that the intramembranous particles of the treated 
cells were free to move on cooling to 0°C but a 
very high concentration of enzyme (1 mg/ml) was 
used in this work (171. However, we also observed 
that human erythrocytes induced to fuse by treat- 
ment with oleoyl glycerol showed a loss of bands 
2.1, 2.2 and 3, and increases in band 2.3, 4.3 and 
4.5 [18]. In addition, changes in the behaviour of 
the intramembranous particles were seen. It was 
therefore suggested that endogenous proteolysis of 
membrane proteins, activated by the perturbing 
fusogen, results in an increased freedom of move- 
ment of membrane proteins that may lead to fu- 
sion, Our more recent work on human 
erythrocytes fused by chlorpromazine has in- 
dicated that a Cat+-insensitive component of this 
fusion reaction is associated with degradation of 
ankyrin (band 2.1) to bands 2.3-2.6 and to smaller 
polypeptides by a serine proteinase [ 191. The 
Ca2+-stimulated component of fusion induced by 
chlorpromazine is related to the degradation of 
band 3 to band 4.5 by a Ca2+-activated cysteine 
proteinase. Proteolysis of ankyrin appeared to be 
sufficient to permit fusion and the intramem- 
branous particles were freed from their attachment 
to the membrane skeleton both in the presence and 
absence of Ca2+ in the fusogen-treated cells, but 
fusion occurred more rapidly when band 3 was 
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also degraded in the presence of Ca2+ 
Unlike the fusion of human erythrocytes by 
chlorpromazine and oleoylglycerol, the fusion of 
rat red blood cells by benzyl alcohol and the 
associated egradation of their membrane proteins 
is prevented by agents that chelate Ca2+ and by iV- 
ethylmaleimide [20]. This indicates that the 
Cat+-activated cysteine proteinase is more impor- 
tant in these cells, and it is interesting that the con- 
tent of calpastatin, an endogenous inhibitor of the 
Ca’+-activated, cysteine proteinase known as cal- 
pain I is extremely small in rat erythrocytes, whiIe 
in human erythrocytes there is much more in- 
hibitor than enzyme [21]. A recent report has 
shown that the fusogenic action of PEG on mouse 
erythrocytes is similarly related to the activity of a 
Ca2+-activated cysteine proteinase in both normal 
red blood cells and with malaria-infected cells 1221. 
A Ca2+-sensitive, cysteine proteinase is also in- 
volved in the breakdown of microtubule-associ- 
ated proteins, a-spectrin and globin that parallels 
the release of microvesicles from the plasma mem- 
brane by fusion in chicken erythrocytes treated 
with ionophore A23187 and Ca’+ [23]. In addition 
Ca2+-activated neutral proteinase activity has been 
reported to appear concomitantly with the fusion 
of rat myoblasts into myotubes, while other pro- 
teases such as cathepsin D and plasminogen ac- 
tivator did not show any change in their activities 
[24]. Interestingly, the fusion of rat myoblasts re- 
quires the activity of a neutral metalloendoprote- 
ase at the time of fusion, although the relationship 
between the requirement for Ca2+ in fusion and 
the activity of the enzyme is at present unknown 
[25]. Furthermore, recent data indicate that synap- 
tic transmission involves a metalloendoprotease in
the pre-synaptic nerve terminal, and that proteoly- 
sis may be an important step in the exocytosis of 
neurotransmitters [26]. 
Protease treatments enhance cell fusion induced 
by PEG [27] and by high pHfhigh Ca2+ [28], but 
not all chemically-induced cell fusion seems to de- 
pend on a proteolytic breakdown of the membrane 
skeleton. Thus, by contrast with the actions of 
PEG on the fusion of mouse erythrocytes, the fu- 
sion of human erythrocytes by PEG has been 
reported not to involve proteolysis of membrane 
proteins 129,301. In human erythrocytes fusion 
may be a consequence of ultrastructural changes in 
the membrane skeleton that are induced by the 
dehydrating action of concentrated solutions of 
PEG 131-331. It has, however, been suggested that 
PEG itself merely induces cell aggregation and 
that, when it is purified and small contaminant 
molecules are removed by recrystallisation, PEG 
does not cause cell fusion [34]. This proposal was 
made on the basis of the behaviour towards 
erythrocytes of commercial PEG-6000 from a par- 
ticular commercial source (Wako Pure Chemical 
Industries Ltd). We have found that erythrocytes 
treated with recryst~lized PEG (Wako) for 15 
min, instead of 1 min as in [34], are extensively 
fused 1351. We also found that recrystallizing com- 
mercial preparations of PEG from 4 other sources 
was without effect on their fusogenic properties, 
and none of these preparations was able to fuse 
erythrocytes in 1 min. Unpurified PEG (Wake) 
thus appears to contain impurities that enhance its 
fusogenic action in short incubation periods. It 
also seems that PEG is itself able to fuse cells but 
that, depending on the specific experimental condi- 
tions and the preparation of PEG employed, the 
extent of cell fusion obtained in some applications 
may depend on the enhancement of fusion by con- 
t~inating molecules [36]. In view of the fact that 
concentrations of 35-50% of PEG are required to 
induce cell fusion, small molecules such as oleoyl 
glycerol, chlorpromazine and benzyl alcohol 
would nevertheless eem to be more appropriate 
models than PEG for the unknown chemical 
mediators of biomembrane fusion reactions in 
vivo, regardless of the undoubted value of PEG as 
a laboratory tool. 
3, MEMBRANE LIPIDS 
3. I I) Cakium ions 
A simple function of Ca2’ in fusion reactions 
would be to neutralize the surface charges of mem- 
branes, contributed by the proteins or by 
phospholipids, but it has been pointed out that one 
should not expect Ca2+ to act only by screening 
negative charges on membranes otherwise very 
high concentrations of internal Mg2+ would 
enhance neutrotransmitter elease ]37]. Further- 
more, two phospholipid membranes that are closer 
than about 30 A repel each other with a force that 
is apparently only weakly dependent on membrane 
charge, and removal of water from the polar 
225 
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groups that stabilize the membrane surface is pro- 
bably more important in allowing membranes to 
become closely apposed. It has therefore been sug- 
gested that Ca2+ may act to trigger a 
phospholipase that removes polar groups, and 
hence water, from the phospholipid bilayers of 
membranes [37]. Since lysophosphatidylcholine is 
fusogenic [38] another possibility is that Ca2+ 
stimulates its production by a phospholipase but 
there is little evidence for lysophospholipids being 
mediators of biomembrane fusion other than 
under experimental conditions. 
An interesting recent paper has reported that 
phosphatidylinositol 4-phosphate and phosphati- 
dylinositol4,5-bisphophate are degraded, and dia- 
cylglycerol and phosphatidic acid are formed, 
when fusion-competent, chick embryonic myo- 
blasts are stimulated to fuse by increasing the con- 
centration of Ca2+ in the medium to 1.4 mM [39]. 
Similar findings were made with phosphatidylino- 
sitol itself but other common phospholipids were 
unaffected [40]. Sr2+, which can replace Ca2+ in 
stimulating myoblast fusion, also stimulated the 
breakdown of all 3 inositol phospholipids, whereas 
Mg2+ inhibited both the Ca2+-stimulated fusion 
and breakdown of the phospholipids. As the 
breakdown of phosphatidylinositol 4,5-bisphos- 
phate may be a primary event in Ca2+-gating in 
membranes, and since Ca2+ is now known to enter 
myoblasts before fusion [41], it was suggested that 
the changes in myoblast phospholipids are part of 
a gating process for extracellular Ca’+. 
Since 1974 Papahadjopoulos and his colleagues 
have developed a general theory for the role of 
Ca2+ in membrane fusion reactions on the basis of 
an extensive series of investigations on the behavi- 
our of phospholipids as a model system for the in- 
vestigation of biomembrane fusion reactions. In 
particular, observations made on the mechanism 
of the Ca2+-induced fusion of phosphatidylserine 
vesicles were taken to indicate that a phase change 
from a fluid to a solid state is a key factor in fusion 
induced by Ca2+ [42]. They proposed that the 
crucial event in fusion responsible for triggering 
most, and perhaps all membrane fusion pheno- 
mena, is a Ca2+ -induced separation of acidic phos- 
pholipids such as phosphatidylserine into rigid 
crystalline domains, with fusion occurring at do- 
main boundaries between adjacent membranes 
[43]. This was put forward as a single mechanism 
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to explain extracellular and intracellular fusion 
reactions, and they have subsequently shown that 
Mg2+ [44], the protein synexin [45], phosphate 
ions [46] and polyamines [47] each decrease the 
concentration of Ca2+ required for the fusion of 
vesicles containing phosphatidylserine mixed with 
other phospholipids. 
However, apart from the fact that relatively 
small quantities of phosphatidylserine are present 
in the majority of biomembranes, it does not 
follow that the requirement for Ca2+ in fusion oc- 
curring in vivo simply reflects an involvement of 
Ca2+ in the fusion of acidic phospholipid bilayers, 
particularly as under some conditions 
phospholipid vesicles fuse in the absence of Ca2+ 
or in the presence of chelating agents. For exam- 
ple, it has been reported that fusion is induced in 
1 min by 50% PEG when unilamellar vesicles of 
egg phosphatidylcholine and even of bovine 
phosphatidylserine, are treated in aqueous buffer 
containing 0.2 M EDTA; in this work fusion was 
monitored by electron microscopy and by turbidity 
measurements [48]. With a mixture of egg 
phosphatidylcholine, egg phosphatidic acid and 
cholesterol (molar ratios of 7 : 2 : l), large vesicles 
were observed after 3 h with 30% PEG in the 
absence of added Ca2+ [32]. Changes consistent 
with vesicle fusion have also been noted in studies 
on the calorimetric behaviour of mixed 
phospholipids in the presence of PEG and 5 mM 
EDTA [49], and alkyl bromide-induced fusion of 
both egg phosphatidylcholine and phosphatidyl- 
choline/phosphatidic acid vesicles shows no 
dependence on the concentration of Ca2+ over a 
range of 0.5 to 10 mM assayed either by light-scat- 
tering or by microscopy [50]. There are, further- 
more, a number of reports on the fusion of phos- 
pholipid vesicles occurring on treatment with pep- 
tides and proteins either in the absence of Ca2+ or 
in the presence of EGTA [51-561. 
Erythrocytes fuse in the presence of EGTA when 
they are treated with oleoylglycerol or chlor- 
promazine as mentioned [18,191, or with tetracaine 
[57], or Sendai virus [58,59] and it has been sug- 
gested that the entry of Ca2+ into Sendai virus- 
treated erythrocytes is a consequence and not a 
cause of the fusion event [60]. Even some fusion of 
chick myoblasts (but not rat myoblasts) occurs in 
high-density cultures in 1.75 mM EGTA [61]. Ad- 
ditionally, the toxic effects of PEG are decreased, 
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and the yield of hybrid cells is increased, when 
PEG is used in a Ca ‘+-free medium and the cells 
then maintained in Ca2+-free medium for at least 
15 min [62]. In the light of these data and those on 
the fusion of liposomes without Ca2+ it seems un- 
likely that a direct interaction of Ca2+ with acidic 
phospholipids is a major factor in membrane fu- 
sion in vivo. Ca2+ may well be more involved in 
other aspects of biomembrane fusion reactions, 
possibly involving membrane proteins as discussed 
above. 
3.2. bob-bi~~yer phases 
What happens to the structures of the lipid 
bilayers when two closely apposed biomembranes 
fuse? An intermediate structure of lower stability 
than a bilayer seems likely to occur as a transient 
intermediate. One of the first proposals for a tran- 
sient non-bilayer phase in membrane fusion reac- 
tions was the suggestion that globular micelles 
might be involved [63]. This was based on the 
known effects of lysolecithin on the structures of 
phospholipid membranes and its ability to fuse 
erythrocytes. Other workers have proposed that a 
semi-micelle configuration might be formed [64], 
and the participation of inverted micelles in fusion 
induced by alamethicin [51] and by membrane 
mobility agents [65] has been suggested. 
In early studies, a hexagonal phase was also 
observed, by electron microscopy, when 
phospholipids were treated with fusogenic lipids, 
e.g., oleic acid, but not when corresponding non- 
fusogenic lipids were used, e.g., stearic acid [66]. 
In the last 5 years a large number of papers 
devoted to NMR studies of membranes and model 
systems treated with chemical fusogens and Ca2+ 
have been published, in which the authors sug- 
gested a common mechanism of action for 
fusogenic lipids whereby structures, such as long 
cylinders of the hexagonal HII phase (or inverted 
micelles, see below) are formed that serve as in- 
termediates in the fusion event [67,68]. No X-ray 
diffraction data in support of this hypothesis ap- 
pear to have been published yet, however, and it is 
relevant to note that it is conceivable that NMR 
spectra attributed to a hexagonal phase may ac- 
tually correspond to a minor change in the 
organisation of bilayer phospholipids. Indeed, a 
theoretical study has shown that it is possible to 
generate spectra, considered to be typical of the 
hexagonal HJI phase, simply by changing the con- 
formation of the phospholipid head group of 
phosphatidylethanolamine while retaining the 
molecules in the bilayer 1691. On a separate point, 
even if the hexagonal phase is a fusion in- 
termediate in centrifuged, packed preparations of 
erythrocyte ghosts [68], the possibility remains that 
it is not involved when fusion occurs between in- 
dividual pairs of biomembranes in vivo. 
Small particles (60-120 A diameter) have been 
seen on the fracture faces in related freeze-fracture 
studies of lipid systems that exhibit the NMR spec- 
tra attributed to the hexagonal phase, and it has 
been suggested that the particles represent inverted 
micelles lying within the phospholipid bilayers 
[70]. It has also been proposed that factors, which 
promote the Hn phase in multilamellar systems, 
cause fusion in unilamellar vesicles via inverted 
micelles 171,721 but other workers consider that the 
lipidic particles seen in these experiments are 
artefacts [73]. 
Thus, although most investigators would pro- 
bably agree that a non-bilayer structure of some, 
kind probably occurs as an intermediate in fusion, 
there is no consensus on its nature even in model 
systems let alone in vivo. Also, it is not impossible 
that in various membranes, fusing under differing 
conditions, different intermediates may be 
involved. 
4. LIPID-PROTEIN INTERACTIONS 
4.1. Fusogenic viral polypeptides 
Membrane fusion induced by certain enveloped 
viruses is the only case of naturally-occurring 
biomembrane fusion in which the molecular in- 
itiators of the process are known. Thus with 
paramyxoviruses, e.g., Sendai virus particles 
(which fuse with the plasma membranes of cells 
and induce cell fusion), and with viruses such as 
the Semliki Forest virus and influenza virus (which 
fuse with the membranes of endocytic vacuoles at 
low pH) the fusogenic agents are glycoproteins. 
The F glycoprotein of Sendai virus has a 
hydrophobic sequence at its amino end that is 
thought to interact with the target membrane [74]. 
Despite its highly hydrophobic nature, the N- 
terminal segment is readily attacked by proteolytic 
enzymes [75]: this indicates that the segment is ex- 
posed to the surrounding aqueous medium. At pH 
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9, the optimum for fusion by Sendai virus, a con- 
formational change occurs that may allow the 
hydrophobic sequence to interact with the target 
membrane [76]. The haemagglutinin glycoprotein 
HA of influenza virus similarly undergoes a con- 
formational change at low pH to expose a 
hydrophobic amino-terminal segment [77]. 
How these hydrophobic peptide sequences ac- 
tually perturb membranes to induce fusion is 
unknown but further support for the importance 
of the aggregation of intramembranous particles in 
fusion induced by Sendai virus has come from a re- 
cent finding that the inclusion of high concentra- 
tions of anti-spectrin antibody within erythrocyte 
ghosts simultaneously inhibits clustering of the 
particles and fusion [78]. In addition to its 
fusogenic glycoprotein, the virus may therefore 
need to possess proteolytic activity towards the 
membrane skeleton or cell cytoskeleton to which 
the integral membrane proteins are normally at- 
tached. Hence it is interesting that fusion of 
Ehrlich ascites-tumour cells by Sendai virus is in- 
hibited by proteolytic inhibitors [79]. Recently, 
also, proteolytic activity has been found in Sendai 
virus that degrades band 3 in human erythrocytes; 
several inhibitors of proteolytic enzymes inhibited 
the activity of the enzyme and the fusion of 
erythrocytes by the virus. It was therefore sug- 
gested that the viral protease may remove mem- 
brane glycoproteins to expose the phospholipids to 
the viral hydrophobic glycoprotein [80]. 
4.2. Hypothesis 
Do hydrophobic peptides or proteins initiate any 
of the innumerable biomembrane fusion reactions 
that occur, without the aid of viruses, in the nor- 
mal behaviour of mammalian cells? In [81] authors 
remarked that fusogenic viruses may have acquired 
the mechanism by which they induce fusion from 
a pre-existing cellular mechanism and, in view of 
the associations between fusion and proteolysis 
discussed above, I have recently suggested that en- 
dogenous cellular proteinases may release 
hydrophobic fragments (derived from integral pro- 
teins at the cytoplasmic surface or from membrane 
skeleton proteins) that perturb the lipid bilayers of 
cells and thus induce fusion [82]. Cell fusion in- 
duced in this way would be complementary to that 
caused by penetration into the lipid bilayer from 
outside cells of the fusogenic glycoprotein of Sen- 
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dai virus. The production in situ of fusogenic pep- 
tides or proteins by endogenous proteinases, which 
are activated in vivo by appropriate stimuli, might 
however be a general mechanism for the fusion of 
biomembranes in a wide variety of situations, in- 
cluding endocytosis and exocytosis. It may be 
significant in this connection that, when Sendai 
virus is grown in chick embryos it contains the 
fusogenic Fi glycoprotein, but that when grown in 
bovine kidney (MDBK) cells it contains the precur- 
sor Fo that is inactive in fusion. Thus, activation is 
dependent on cleavage of a viral protein by a 
cellular enzyme [83]. 
The literature contains a number of reports on 
the fusogenic behaviour of (non-viral) peptides 
and proteins. For example, two amphipathic 
polypeptides, melittin [55,56] and alamethicin 
[51], which are structurally related and contain 
lipophilic amino acids in their N-terminal regions, 
fuse phospholipid vesicles. Proteins that have been 
reported to fuse phospholipid vesicles include 
tobacco mosaic virus coat protein [54], con- 
canavalin A [52] and, rather surprisingly, serum 
albumin [53]. It is conceivable, however, that 
relatively non-polar sections of soluble proteins 
may induce membrane fusion, particularly since 
sequences of some 20 hydrophobic amino acid 
residues can occur in the folded interior of 
globular proteins. Similarly, when a peripheral 
membrane protein is degraded by proteolysis, 
hydrophobic segments can be released some of 
which could be fusogenic. Spectrin, for example, 
contains hydrophobic regions which are thought to 
occur in cu-helical domains that are linked by 
protease-sensitive loops. Ankyrin also contains a 
substantial hydrophobic domain, and it is relevant 
to the possible general applicability of the present 
hypothesis that cells other than erythrocytes have 
structures that are comparable to the spectrin-actin 
skeleton of the erythrocyte membrane [15,161. It is 
also interesting that myelin basic protein will fuse 
erythrocytes in the presence of Ca’+ but that a 
mixture of sulphatides and myelin basic protein is 
not fusogenic [84]; i.e., the dissociation of 
molecules that normally co-exist in membranes can 
yield components that are membrane-disruptive 
and fusogenic. 
What is known about the possible importance of 
the products of proteolysis in biomembrane fusion 
occurring in vivo? Many inflammatory cells, in- 
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eluding mast cells and neutrophils, can be ac- 
tivated by the addition of exogenous proteases, 
and the secretory activities of a number of them 
are inhibited by inhibitors of serine proteases. 
Platelet protein band 2 is cleaved into two 
fragments concurrently with platelet aggregation, 
and it has been proposed that on stimulation a 
Ca’+-dependent proteolytic activity appears on the 
platelet surface and that proteolysis of band 2 oc- 
curs on platelet aggregation 1851. Another 
secretory membrane system of interest in the pre- 
sent context is the exocytosis of the cortical 
granules of egg cells that accompanies fertilization. 
A limited proteolysis of surface proteins has been 
observed following fertilization of sea urchin eggs 
and several proteins are present in greatly reduced 
quantities in the plasma membrane after fertiliza- 
tion [86]. Authors in [87] have suggested that the 
release of protein is related to the rise in in- 
tracellular Ca*+ that induces the exocytosis reac- 
tion, and they have speculated on whether the 
released polypeptides have a functional role. It is 
not known how an increase in cytoplasmic Ca*+ 
promotes exocytosis. It is interesting however, in 
relation to the inhibition by ~-ethylmaleimide of 
the Ca*+-stimulated fusion of erythrocytes and the 
associated proteolysis discussed above, that this 
thiol agent inhibits the exocytosis of egg cortical 
granules and also protects the granules from a 
spontaneous breakdown that occurs on incubation 
at 20°C [88]. 
Certain polypeptide hormones have been shown 
to stimulate the fusion of intracellular vesicles with 
the plasma membrane to increase the number of 
transporters for water (vasopressin on toad blad- 
der cells) and for glucose (insulin on fat cells) [89]. 
However, should fusogenic peptides be involved in 
either of these two systems they are unlikely to be 
derived from the hormones themselves, despite 
their relatively high contents of non-polar amino 
acids, because the action of vasopressin is 
reproduced by dibutyryl cyclic AMP and it is pro- 
bably unnecessary for insulin to enter cells to 
stimulate glucose transport. Functional fusogenic 
peptides or polypeptides may nevertheless be 
generated from non-membranous proteins in some 
circumstances. For instance, the importance of 
hydrophobic amino acid residues in the signal se- 
quence of secreted proteins is well established, but 
relatively little is known about the fate of such se- 
quences after their release by a signal peptidase 
[90]. If signal peptides are not further degraded 
but accumulate within the endoplasmic reticulum 
they may perhaps participate in one or more of the 
membrane fusion reactions that mediate the 
pathways followed by enzymes and proteins 
destined for secretion. 
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